Why J&J thinks its new psoriasis pill could be one of its biggest drugs ever

Johnson & Johnson's new psoriasis pill, Icotyde, is expected to accelerate the company's revenue growth rate, making it one of its biggest drugs ever. Investors are counting on this drug to drive growth. The pill's success could have a significant impact on J&J's financial performance.